Detalhe da pesquisa
1.
Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters.
Toxicol Appl Pharmacol
; 484: 116866, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38367674
2.
3D-QSAR, molecular docking, molecular dynamics, and ADME/T analysis of marketed and newly designed flavonoids as inhibitors of Bcl-2 family proteins for targeting U-87 glioblastoma.
J Cell Biochem
; 123(2): 390-405, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34791695
3.
The Impact of D614G Mutation of SARS-COV-2 on the Efficacy of Anti-viral Drugs: A Comparative Molecular Docking and Molecular Dynamics Study.
Curr Microbiol
; 79(8): 241, 2022 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35792936
4.
Niosomal virosome derived by vesicular stomatitis virus glycoprotein as a new gene carrier.
Biochem Biophys Res Commun
; 534: 980-987, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33131770
5.
Antioxidant enzyme activities, molecular docking studies, MM-GBSA, and molecular dynamic of chlorpyrifos in freshwater fish Capoeta umbla.
J Biomol Struct Dyn
; 42(1): 163-176, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-36974945
6.
Tracing the pathways and mechanisms involved in the anti-breast cancer activity of glycyrrhizin using bioinformatics tools and computational methods.
J Biomol Struct Dyn
; 42(2): 819-833, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37042955
7.
Investigation on the mechanisms by which the herbal remedies induce anti-prostate cancer activity: uncovering the most practical natural compound.
J Biomol Struct Dyn
; 42(7): 3349-3362, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37194430
8.
Structure-Based Drug Design for Targeting IRE1: An in Silico Approach for Treatment of Cancer.
Drug Res (Stuttg)
; 74(2): 81-88, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134918
9.
Synthesis and cytotoxic activity evaluation of novel imidazopyridine carbohydrazide derivatives.
BMC Chem
; 18(1): 6, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184605
10.
Evaluation of the FDA-approved kinase inhibitors to uncover the potential repurposing candidates targeting ABC transporters in multidrug-resistant cancer cells: an in silico approach.
J Biomol Struct Dyn
; : 1-13, 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942620
11.
Modeling and affinity maturation of an anti-CD20 nanobody: a comprehensive in-silico investigation.
Sci Rep
; 13(1): 582, 2023 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36631511
12.
Comparison of Protective Effects of Phenolic Acids on Protein Glycation of BSA Supported by In Vitro and Docking Studies.
Biochem Res Int
; 2023: 9984618, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37496561
13.
Design, synthesis, in silico ADME, DFT, molecular dynamics simulation, anti-tyrosinase, and antioxidant activity of some of the 3-hydroxypyridin-4-one hybrids in combination with acylhydrazone derivatives.
J Biomol Struct Dyn
; : 1-11, 2023 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674457
14.
Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles.
J Control Release
; 343: 777-797, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35183653
15.
In silico SELEX screening and statistical analysis of newly designed 5mer peptide-aptamers as Bcl-xl inhibitors using the Taguchi method.
Comput Biol Med
; 146: 105632, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617726
16.
Evaluation of potential anti-RNA-dependent RNA polymerase (RdRP) drugs against the newly emerged model of COVID-19 RdRP using computational methods.
Biophys Chem
; 272: 106564, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33711743
17.
Correction: Structure-Based Drug Design for Targeting IRE1: An in Silico Approach for Treatment of Cancer.
Drug Res (Stuttg)
; 74(2): e1, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38211623